retatrutide clinical trial information Shows 28% Weight Loss in 80 Weeks retatrutide weight loss retatrutide clinical

It is not intended nor implied to be a substitute for professional medical advice

These next-generation drugs go beyond the mechanisms of current GLP-1 medications such as Ozempic, Wegovy, Semaglutide, and Mounjaro , introducing multi-hormone metabolic therapies and even oral alternatives

We need to monitor your progress and adjust your dosages as needed to optimize your results

Potential Synergistic Benefits Research suggests HRT may actually enhance weight loss outcomes in menopausal women

Provincial Healthcare Considerations When these medications eventually receive Health Canada approval, provincial drug coverage decisions will determine accessibility for many Canadians